Austin D.
- Country
- Ireland
- Department
- Medical Oncology
Research Overview
- Evaluation of Pharmacokinetics and Safety of Intravenous ABBV-969 in Adults with Metastatic Castration-Resistant Prostate Cancer
- Phase 1/1b Evaluation of IAM1363 in Patients with Relapsed/Refractory HER2-Altered Malignancies
- Phase 1 Evaluation of NDI-219216 in Advanced Solid Tumors with/without Microsatellite Instability and Deficient Mismatch Repair
Data & Insights
Has run more than one trial at 65 of 158 partner sites.
Specializations
Oncology Research
The investigator specializes in advanced solid tumor research, with particular emphasis on gynecological cancers and innovative therapeutic approaches.
- Recurrent Ovarian Cancer
- Endometrial Cancer
- Cervical Cancer
- NSCLC Treatment
Research extends to targeted therapies for specific tumor mutations and expressions.
Immunotherapy Focus
Expertise in immune checkpoint inhibitor treatments and their combination with novel therapeutic agents.
- Monoclonal Antibody Therapies
- Combination Treatment Strategies
- Pembrolizumab Applications
Investigates immunotherapeutic approaches across various cancer types.
Gastrointestinal Oncology
Focused on treating advanced gastrointestinal malignancies through innovative therapeutic combinations.
- Colorectal Cancer
- Pancreatic Cancer
- Cholangiocarcinoma
- Gastric Cancer
Explores combination chemotherapy approaches with novel agents.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
